| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$49,374,432 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$49,374,432 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -34.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TECH |
Techne Corp |
Director |
– • – |
2020-02-12 |
4 |
OE |
$61.46 |
$307,300 |
D/D |
5,000 |
9,021 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2019-06-04 |
4 |
OE |
$63.03 |
$315,150 |
D/D |
5,000 |
8,526 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-11-17 |
4 |
S |
$140.34 |
$316,888 |
D/D |
(2,258) |
141,284 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2024-05-14 |
4 |
S |
$83.84 |
$335,377 |
D/D |
(4,000) |
36,608 |
0 |
% |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-04-28 |
4 |
OE |
$21.85 |
$349,600 |
D/D |
16,000 |
39,360 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-04-28 |
4 |
D |
$79.88 |
$349,635 |
D/D |
(4,377) |
34,983 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-12-28 |
4 |
D |
$66.29 |
$350,608 |
D/D |
(5,289) |
417,695 |
0 |
- |
|
| TECH |
Techne Corp |
|
– • – |
2020-11-06 |
4 |
OE |
$70.35 |
$351,750 |
D/D |
5,000 |
9,412 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2016-09-22 |
4 |
S |
$117.34 |
$352,020 |
D/D |
(3,000) |
122,664 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-03-08 |
4 |
S |
$107.06 |
$428,240 |
D/D |
(4,000) |
128,969 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2013-08-16 |
4 |
S |
$42.85 |
$428,500 |
D/D |
(10,000) |
110,025 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-03-20 |
4 |
AS |
$109.10 |
$436,400 |
D/D |
(4,000) |
139,171 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-02-15 |
4 |
D |
$104.28 |
$448,821 |
D/D |
(4,304) |
118,360 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-13 |
4 |
D |
$95.68 |
$479,261 |
D/D |
(5,009) |
196,730 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-13 |
4 |
OE |
$9.96 |
$479,325 |
D/D |
48,125 |
201,739 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-02-24 |
4 |
D |
$100.38 |
$480,118 |
D/D |
(4,783) |
122,745 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-11-12 |
4 |
S |
$160.50 |
$481,500 |
D/D |
(3,000) |
335,095 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-03-06 |
4 |
D |
$165.87 |
$494,624 |
D/D |
(2,982) |
107,419 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-02-15 |
4 |
D |
$97.23 |
$497,429 |
D/D |
(5,116) |
205,173 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2015-08-06 |
4 |
S |
$110.79 |
$516,946 |
D/D |
(4,666) |
121,378 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-01-10 |
4 |
OE |
$16.14 |
$545,371 |
D/D |
33,790 |
119,209 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2013-10-18 |
4 |
AS |
$55.00 |
$550,000 |
D/D |
(10,000) |
106,581 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-06-21 |
4 |
AS |
$120.00 |
$559,920 |
D/D |
(4,666) |
139,171 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-02-15 |
4 |
D |
$120.86 |
$594,269 |
D/D |
(4,917) |
133,982 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-02-05 |
4 |
D |
$203.03 |
$602,999 |
D/D |
(2,970) |
343,060 |
0 |
- |
|
165 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
